Journal of Internal Medicine 2006: Vol 259 Index & Table of Contents

2006·2.3 MB·English

Journal of Internal Medicine 2006; 259: 619-622
Author index
Aastveit, A. see Sniderman, A.D. Caro-Sampara, F. see Mandache, C.
Aastveit, A.H. see Walldius, G. Carpagnano, G.E., Resta, O., Ventura, M.T., Amoruso, A.C., Di
Abbink, E.J., de Graaf, J., de Haan, J.H., Heerschap, A., Stalenhoef, Gioia, G., Giliberti, T., Refolo, L. & Foschino-Barbaro, M.P.
A.F. & Tack, C.J. Effects of pioglitazone in tamilial combined Airway inflammation in subjects with gastro-oesophageal
hyperlipidaemia, 107 reflux and gastro-oesophageal reflux-related asthma, 323
Abildgaard, U. see Njaastad, A.M. Castier, Y. see Lehoux, S.
Abildstrom, S.Z. see Friberg, J. Castro Cabezas, M. see Barter, P.J.
Acosta, S., Ogren, M., Sternby, N.-H., Bergqvist, D. & Bjorck, M. Cederholm, J. for the Steering Committee of the Swedish National
Fatal nonocclusive mesenteric ischaemia: population-based Diabetes Register (NDR). see Ridderstrale, M.
incidence and risk factors, 305 Cerrone, M., Noujaim, S. & Jalife, J. The short OT syndrome as a
Albertsson, P. see Solem, J. paradigm to understand the role of potassium channels in
Alexandersen, P. see Bagger, Y.Z. ventricular fibrillation, 24
Amoruso, A.C. see Carpagnano, G.E. Chang, C.-M. see Lee, H.-C.
Andersen, A. see Frostad, A. Charlton-Menys, V. & Durrington, P. Apolipoproteins AI and B as
Anderson, M.E. QT interval prolongation and arrhythmia: an therapeutic targets, 462
unbreakable connection?, 81 Chen, W. see Harrison, D.G.
Andolf, E. see Pegelow Halvorsen, C. Christensen, S. see Thomsen, R.W.
Andrés, E. see Mandache, C. Christiansen, C. For the Prospective Epidemiological Risk Factors
Antzelevitch, C. & Oliva, A. Amplification of spatial dispersion of Study Group. see Bagger, Y.Z.
repolarization underlies sudden cardiac death associated with Chuang, Y.-C. see Lee, H.-C.
catecholaminergic polymorphic VT, long QT, short QT and Cleland, J.G.F. see Loh, P.H.
3rugada syndromes, 48 Coca, C. see Mandache, C.
Cohen, I.S. see Rosen, M.R.
3agger, Y.Z., Tanko, L.B., Alexandersen, P., Qin, G. & Christiansen, Cook, J. see Loh, P.H.
C. For the Prospective Epidemiological Risk Factors Study Coumaros, D. see Mandache, C.
Group. Radiographic measure of aorta calcification is a Couture, P. see Barter, P.].
site-specific predictor of bone loss and fracture risk at the hip,
598 Danesh, J. see Thompson, A.
Ballantyne, C.M. see Barter, P.J. Deeb, S.S. see Zambon, A
Barter, P.J. & Rye, K.-A. The rationale for using apoA-I as a Di Gioia, G. see Carpagnano, G.E.
clinical marker of cardiovascular risk, 447 van Die, C.E. see van der Meer, J.W.M.
Barter, P.J., Ballantyne, C.M., Carmena, R., Castro Cabezas, M., Durrington, P. see Charlton-Menys, V.
John Chapman, M., Couture, P., de Graaf, J., Durrington, Durrington, P.N. see Barter, P.J.
P.N., Faergeman, O., Frohlich, J., Furberg, C.D., Gagne, C
Haffner, S.M., Humphries, S.E., Jungner, I., Krauss, R.M., Ehrnstrém, B. see Eriksson, J.G.
Kwiterovich, P., Marcovina, S., Packard, C.J., Pearson, Eliasson, B. see Ridderstrale, M.
T.A., Srinath Reddy, K., Rosenson, R., Sarrafzadegan, N., Eng, C. see Lim, L.C
Sniderman, A.D., Stalenhoef, A.F., Stein, E., Talmud, P.]J. Engstrém, G. see Gerward, S.
lonkin, A.M., Walldius, G. & Williams, K.M.S. Apo B ‘ricsson, C.-G. see Samnegard, A.
versus cholesterol in estimating cardiovascular risk and in Eriksson, J.G., Lehtovirta, M., Ehrnstrém, B., Salmela, S. & Groop,
guiding therapy: report of the thirty-person/ten-country L. Long-term beneficial effects of glipizide treatment on
panel, 247 glucose tolerance in subjects with impaired glucose tolerance,
van den Berg, B. see Gouverneur, M. 553
3ergfeldt, L. Introduction: ‘The long QT syndromes — from Eriksson, P. see Samnegard, A.
molecule to man’, 4 Ernst, E. Acupuncture — a critical analysis, 125
3ergqvist, D. see Acosta, S.
Bergstrom, H. & Tonstad, S. Combined hormone replacement
therapy improves lipids but may increase leucocytes, 537 Faergeman, O. see Barter, P.].
Faergeman, QO. Introduction: Apolipoproteins and guidelines for
Bjorck, M. see Acosta, S.
Blicklé, F. see Mandache, C. prevention of cardiovascular disease, 434
Blomjous, C.E.M. see van der Meer, J.W.M. de Faire, U. Journal of Internal Medicine: a journal for the future,
3onaa, K.H. see Svartberg, J. l
Farkkila, M. see Stjernberg-Salmela, S.
30onen, S., Vanderschueren, D., Haentjens, P. & Lips, P. Calcium
and vitamin D in the prevention and treatment of osteo- Foschino-Barbaro, M.P. see Carpagnano, G.E.
porosis — a clinical update, 539 Frangos, J.A. see Intaglietta, M.
Bredie, S.J.H. see van der Meer, J.W.M. Friberg, J.. Gislason, G.H., Gadsbell, N., Rasmussen, J.N.,
Brown, B.G. see Zambon, A. Rasmussen, S., Abildstrom, S.Z., Kober, L., Madsen, M. &
Torp-Pedersen, C. Temporal trends in the prescription of
Brunzell, J.D. see Zambon, A.
vitamin K antagonists in patients with atrial fibrillation,
Bruun Wyller, T. see Fure, B.
173
Frohlich, J. see Barter, P.J.
Cabrales, P. see Martini, J. Frostad, A., Soyseth, V., Andersen, A. & Gulsvik, A. Respiratory
Caplin, J. see Loh, P.H. symptoms as predictors of all-cause mortality in an urban
Carlsson, L.G. In vitro and in vivo models for testing arrhythmo- community: a 30-year follow-up, 520
genesis in drugs, 70 Fujiwara, K. Platelet endothelial cell adhesion molecule-1 and
Carmena, R. see Barter, P.J. mechanotransduction in vascular endothelial cells, 373
© 2006 Blackwell Publishing Ltd 619
620 AUTHOR INDEX
Furberg, C.D. see Barter, P.J. Jousilahti, P. see Patja, K.
Fure, B., Bruun Wyller, T. & Thommessen, B. Electrocardiographic Jungner, I. see Barter, P.J.
and iroponin T changes in acute ischaemic stroke, 592 Jungner, I. see Sniderman, A.D.
Jungner, I. see Walldius, G.
Gadsboll, N. see Friberg, J.
Karlsson, T. see Solem, J.
Gagne, C. see Barter, P.J.
Kauma, H. see Ruotsalainen, E.
Gerward, S., Tydén, P., Hansen, O., Engstrém, G., Janzon, L. &
Kemppainen, E. see Stjernberg-Salmela, S.
Hedblad, B. Survival rate 28 days after hospital admission
Kenemans, P. see Verhoeven, M.O.
with first myocardial infarction. Inverse relationship with
Kivisaari, A. see Stjernberg-Salmela, S.
socio-economic circumstances, 164
Ko, N.-Y. see Lee, H.-C.
Giliberti, T. see Carpagnano, G.E.
Ko, W.-C. see Lee, H.-C.
Gislason, G.H. see Friberg, J.
Kober, L. see Friberg, J.
Gouverneur, M., van den Berg, B., Nieuwdorp, M., Stroes, E. &
Koivula, I. see Ruotsalainen, E.
Vink, H. Vasculoprotective properties of the endothelial
Koizumi, A. see Ikeda, A.
glycocalyx: effects of fluid shear stress, 393
Kondo, T. see Ikeda, A.
de Graaf, J. see Abbink, E.J.
Kotilainen, P. see Ruotsalainen, E.
de Graaf, J. see Barter, P.J.
Krauss, R.M. see Barter, P.J.
Grip, L. see Solem, J.
van Krieken, J.H. see van der Meer, J.W.M.
Groop, L. see Eriksson, J.G.
Kwiterovich, P. see Barter, P.J.
Grumbach, I. see Harrison, D.G.
Gudbjérnsdottir, S. see Ridderstrale, M.
Lassen, J.F. see Njaastad, A.M.
Gulsvik, A. see Frostad, A.
Lee, H.-C., Chuang, Y.-C., Yu, W.-L., Lee, N.-Y., Chang, C.-M., Ko,
N.-Y., Wang, L.-R. & Ko, W.-C. Clinical implications of
de Haan, J.H. see Abbink, E.]. hypermucoviscosity phenotype in Klebsiella pneumoniae iso-
Haberstezer, F. see Mandache, C. lates: association with invasive syndrome in patients with
Haentjens, P. see Boonen, S. community-acquired bacteraemia, 606
Haffner, S.M. see Barter, P.J. Lee, N.-Y. see Lee, H.-C.
Hagstrom, E., Lundgren, E., Mallmin, H., Rastad, J. & Hellman, P. Lehoux, S., Castier, Y. & Tedgui, A. Molecular mechanisms of the
Positive effect of parathyroidectomy on bone mineral density vascular responses to haemodynamic forces, 381
in mild asymptomatic primary hyperparathyroidism, 191 Lehtovirta, M. see Eriksson, J.G.
Hamsten, A. see Samnegard, A. Levin, M. see Solem, J.
Hansen, O. see Gerward, S. Li, X. see Sundquist, K.
Harrison, D.G., Widder, J., Grumbach, I., Chen, W., Weber, M. & Lim, L.C., Tan, M.H., Eng, C., Teh, B.T. & Rajasoorya, R.C. Thymic
Searles, C. Endothelial mechanotransduction, nitric oxide carcinoid in multiple endocrine neoplasia 1: genotype-
and vascular inflammation, 351 phenotype correlation and prevention, 428
Hedblad, B. see Gerward, S. Lind, L. see Stenborg, A.
Heerschap, A. see Abbink, E.J. Lips, P. see Boonen, S.
Hellman, P. see Hagstrém, E. Loh, P.H., Louis, A.A., Windram, J.D., Rigby, A.S., Cook, J.,
Hemelaar, M. see Verhoeven, M.O. Hurren, S., Nikolay, N.P., Caplin, J. & Cleland, J.G.F. The
Hokanson, J.E. see Zambon, A. immediate and long-term outcome of enhanced external
Holme, I. see Sniderman, A.D. counterpulsation in treatment of chronic stable refractory
Hu, G. see Patja, K. angina, 276
Hu, J. see Pegelow Halvorsen, C. Louis, A.A. see Loh, P.H.
Humphries, S.E. see Barter, P.J. Lumio, J. see Ruotsalainen, E.
Hurren, S. see Loh, P.H. Lundgren, E. see Hagstrom, E.
McDonald, C.J. see Thomsen, R.W.
Ikeda, A., Iso, H., Toyoshima, H., Kondo, T., Mizoue, T., Koizumi, Madsen, M. see Friberg, J.
A., Inaba, Y., Tamakoshi, A. & JACC Study Group. Parental Mallmin, H. see Hagstrém, E.
longevity and mortality amongst Japanese men and women: Mandache, C., Coca, C., Caro-Sampara, F., Haberstezer, F.,
the JACC Study, 285 Coumaros, D., Blicklé, F. & Andrés, E. A forgotten aetiology of
Inaba, Y. see Ikeda, A.
acute hepatitis in immunocompetent patient: syphilitic
Intaglietta, M. & Frangos, J.A. Introduction: Mechanotransduc- infection, 214
tion and Translational Medicine Workshop, 336 Marcovina, S. & Packard, C.J. Measurement and meaning of
Intaglietta, M. see Martini, J. apolipoprotein AI and apolipoprotein B plasma levels, 437
Iso, H. see Ikeda, A.
Marcovina, S. see Barter, P.J.
Martini, J., Cabrales, P., Tsai, A.G. & Intaglietta, M. Mechan-
JACC Study Group. see Ikeda, A. otransduction and the homeostatic significance of main-
Jacobsen, J. see Thomsen, R.W. taining blood viscosity in hypotension, hypertension and
Jalife, J. see Cerrone, M. haemorrhage, 364
Janzon, L. see Gerward, S. Mascitelli, L. & Pezzetta, F. Tobacco smoke, systemic inflammation
Jarvinen, A. see Ruotsalainen, E. and the risk of type 2 diabetes, 332
Jensen, J.S. see Mogelvang, R. Mathiesen, E. see Svartberg, J.
Joakimsen, O. see Svartberg, J. van der Meer, J.W.M., Weemaes, C.M.R., van Krieken, J.H..,
John Chapman, M. see Barter, P.J. Blomjous, C.E.M., van Die, C.E., Netea, M.G. & Bredie, S.J.H.
Jolobe, O.M.P. The use of B-type natriuretic peptide in the Critical aneurysmal dilatation of the thoracic aorta in young
management of elderly with acute dyspnoea (J Intern Med adolescents with variant hyperimmunoglobulin E syndrome,
2005;258:77-85), 216 615
© 2006 Blackwell Publishing Ltd Journal of Internal Medicine 259: 619-622
AUTHOR INDEX 621
Mizoue, T. see Ikeda, A. Rintala, E. see Ruotsalainen, E.
Mogelvang, R., Scharling, H. & Jensen, J.S. A simple linear model Roden, D.M. Long QT syndrome: reduced repolarization reserve
for the effect of changes in metabolic risk factors on coronary and the genetic link, 59
heart disease, 561 Rosen, M.R. & Cohen, I.S. Molecular/genetic determinants of
Molina, P.E. Opioids and opiates: analgesia with cardiovascular, repolarization and their modification by environmental
haemodynamic and immune implications in critical illness, stress, 7
138 Rosenson, R. see Barter, P.J.
van der Mooren, M.J. see Verhoeven, M.O. Rudy, Y. Modelling and imaging cardiac repolarization abnorm-
Mosekilde, L. see Rejnmark, L. alities, 91
Motulsky, A.G. see Zambon, A. Ruotsalainen, E., Jarvinen, A., Koivula, I., Kauma, H., Rintala, E.,
Mueller, C. The use of B-type natriuretic peptide in the manage- Lumio, J., Kotilainen, P., Vaara, M., Nikoskelainen, J.,
ment of elderly with acute dyspnoea (J Intern Med Valtonen, V. & The Finlevo Study Group. Levofloxacin does
2005;258:77-85) - reply, 217 not decrease mortality in Staphylococcus aureus bacteraemia
von Miihlen, D. see Svartberg, J. when added to the standard treatment: a prospective and
randomized clinical trial of 381 patients, 179
Netea, M.G. see van der Meer, J.W.M. Rye, K.-A. see Barter, P.J.
Nieuwdorp, M. see Gouverneur, M.
Nikolay, N.P. see Loh, P.H. Salmela, S. see Eriksson, J.G.
Nikoskelainen, J. see Ruotsalainen, E. Samnegard, A., Silveira, A., Tornvall, P., Hamsten, A., Ericsson,
Nilsson, P.M. see Ridderstrale, M. C.-G. & Eriksson, P. Lower serum concentration of matrix
Njaastad, A.M., Abildgaard, U. & Lassen, J.F. Gains and losses of metalloproteinase-3 in the acute stage of myocardial infarc-
warfarin therapy as performed in an anticoagulation clinic, tion, 530
296 Sarrafzadegan, N. see Barter, P.J.
Norgaard, M. see Thomsen, R.W. Scharling, H. see Mogelvang, R.
Norman, M. see Pegelow Halvorsen, C. Schwartz, P.J. The congenital long QT syndromes from genotype
Noujaim, S. see Cerrone, M. to phenotype: clinical implications, 39
Searles, C. see Harrison, D.G.
Ogren, M. see Acosta. S. Silveira, A. see Samnegard, A.
Oliva, A. see Antzelevitch, C. Sniderman, A.D., Jungner, I., Holme, [., Aastveit, A. & Walldius,
Orfanos, P. see Trichopoulou, A. G. Errors that result from using the TC/HDL C ratio rather
than the apoB/apoA-l ratio to identify the lipoprotein-related
risk of vascular disease, 455
Packard, C.J. see Barter, P.J.
Sniderman, A.D. see Barter, P.J.
Packard, C.J. see Marcovina, S. Séderberg-Nauclér, C. Does cytomegalovirus play a causative role
Pahakis, M.Y. see Tarbell, J.M. in the development of various inflammatory diseases and
Patja, K., Jousilahti, P., Hu, G., Valle, T., Qiao, Q. & Tuomilehto, J. cancer?, 219
Tobacco smoke, systemic inflammation and the risk of type 2 Solem, J., Levin, M., Karlsson, T., Grip, L., Albertsson, P. &
diabetes — reply, 333 Wiklund, O. Composition of coronary plaques obtained by
Pearson, T.A. see Barter, P.J. directional atherectomy in stable angina: its relation to
Pegelow Halvorsen, C., Andolf, E., Hu, J., Pilo, C., Winbladh, B. & serum lipids and statin treatment, 267
Norman, M. Discordant twin growth in utero and differences in Sorensen, H.T. see Thomsen, R.W.
blood pressure and endothelial function at 8 years of age, 155 Soyseth, V. see Frostad, A.
Pettersson, T. see Stjernberg-Salmela, S. Srinath Reddy, K. see Barter, P.J.
Pezzetta, F. see Mascitelli, L. Stalenhoef, A.F. see Abbink, E.]J.
Pilo, C. see Pegelow Halvorsen, ( , Stalenhoef, A.F. see Barter, P.J.
Psaltopoulou, T. see Trichopoulou, A.
Stein, E. see Barter, P.J.
Puolakkainen, P. see Stjernberg-Salmela, S. Stenborg, A., Terent, A. & Lind, L. Endothelium-dependent
vasodilatation in forearm is impaired in stroke patients, 569
Qiao, Q. see Patja, K. Stensland-Bugge, E. see Svartberg, J.
Qin, G. see Bagger, Y.Z. Sternby, N.-H. see Acosta, S.
Stjernberg-Salmela, S., Kivisaari, A., Puolakkainen, P., Farkkila,
Rajasoorya, R.C. see Lim, L.C. M., Kemppainen, E., Ranki, A. & Pettersson, T. Intra-
Ranki, A. see Stjernberg-Salmela, S. abdominal abscess in a patient with tumour necrosis factor
Rasmussen, J.N. see Friberg, J. receptor-associated periodic syndrome, 209
Rasmussen, S. see Friberg, J. Stroes, E. see Gouverneur, M.
Rastad, J. see Hagstrom, E. Sundquist, K. & Li, X. Coronary heart disease risks in first- and
Refolo, L. see Carpagnano, G.E. second-generation immigrants in Sweden: a follow-up study,
Rejnmark, L., Vestergaard, P. & Mosekilde, L. Fracture risk in 418
patients treated with loop diuretics, 117 Svartberg, J., von Miihlen, D., Mathiesen, E., Joakimsen, O..,
Resta, O. see Carpagnano, G.E. Bonaa, K.H. & Stensland-Bugge, E. Low testosterone levels
are associated with carotid atherosclerosis in men, 576
Ridderstrale, M., Gudbjérnsdottir, S., Eliasson, B., Nilsson, P.M. &
Cederholm, J. for the Steering Committee of the Swedish
National Diabetes Register (NDR). Obesity and cardiovascular Tack, C.J. see Abbink, E.]J.
risk factors in type 2 diabetes: results from the Swedish Talmud, P.J. see Barter, P.J.
National Diabetes Register, 314 Tamakoshi, A. see Ikeda, A.
Rigby, A.S. see Loh, P.H. Tan, M.H. see Lim, L.C.
Riis, A. see Thomsen, R.W. Tanko, L.B. see Bagger, Y.Z.
© 2006 Blackwell Publishing Ltd Journal of Internal Medicine 259: 619-622
AUTHOR INDEX
Tarbell, J.M. & Pahakis, M.Y. Mechanotransduction and the Verhoeven, M.O., Hemelaar, M., van der Mooren, M.J., Kenemans,
glycocalyx, 339 P. & Teerlink, T. Oral, more than transdermal, oestrogen
Tedgui, A. see Lehoux, S. therapy lowers asymmetric dimethylarginine in healthy
Teerlink, T. see Verhoeven, M.O. postmenopausal women: a randomized, placebo-controlled
Teh, B.T. see Lim, L.C. study, 199
Terent, A. see Stenborg, A. Vestergaard, P. see Rejnmark, L.
The Finlevo Study Group. see Ruotsalainen, E. Vink, H. see Gouverneur, M.
Thommessen, B. see Fure, B.
Thompson, A. & Danesh, J. Associations between apolipoprotein Walldius, G. & Jungner, I. The apoB/apoA-lI ratio: a strong, new
B, apolipoprotein AI, the apolipoprotein B/AI ratio and risk factor for cardiovascular disease and a target for lipid-
coronary heart disease: a literature-based meta-analysis of lowering therapy — a review of the evidence, 493
prospective studies, 481 Walldius, G., Aastveit, A.H. & Jungner, I. Stroke mortality and the
Thomsen, R.W., Riis, A., Norgaard, M., Jacobsen, J., apoB/apoA-l ratio: results of the AMORIS prospective study,
Christensen, S., McDonald, C.J. & Sorensen, H.T. Rising 259
incidence and persistently high mortality of hospitalized Walldius, G. see Barter, P.J.
pneumonia: a 10-year population-based study in Walldius, G. see Sniderman, A.D.
Denmark, 410 Wang, L.-R. see Lee, H.-C.
Tonkin, A.M. see Barter, P.J. Weber, M. see Harrison, D.G.
Tonstad, S. see Bergstrom, H.
Weemaes, C.M.R. see van der Meer, J.W.M.
Tornvall, P. see Samnegard, A. Widder, J. see Harrison, D.G.
Torp-Pedersen, C. see Friberg, J Wiklund, O. see Solem, J.
Toyoshima, H. see Ikeda, A. Williams, K.M.S. see Barter, P.J.
Trichopoulos, D. see Trichopoulou, A. Winbladh, B. see Pegelow Halvorsen, C.
Trichopoulou, A., Psaltopoulou, T., Orfanos, P. & Trichopoulos, D. Windram, J.D. see Loh, P.H.
Diet and physical activity in relation to overall mortality
amongst adult diabetics in a general population cohort, 583
Tsai, A.G. see Martini, ] Yu, W.-L. see Lee, H.-C.
Tuomilehto, J. see Patja, K.
Tydén, P. see Gerward, S. Zambon, A., Brown, B. & Brunzell, J.D. Genetics of
apolipoprotein B and apolipoprotein AI and premature
Vaara, M. see Ruotsalainen, I coronary artery disease, 473
Valle, T. see Patja, K Zambon, A., Brown, B.G., Hokanson, J.E., Motulsky, A.G. &
Valtonen, V. see Ruotsalainen, | Brunzell, J.D. Genetically determined apo B levels and peak
Vanderschueren, D. see Boonen, S. LDL density predict angiographic response to intensive lipid-
Ventura, M.T. see Carpagnano, G.I lowering therapy, 401
© 2006 Blackwell Publishing Ltd Journal of Internal Medicine 259: 619-622
Journal of Internal Medicine 2006; 259: 623-624
Keyword index
action potential, 81 ECG, 592 LDL, 437
acupuncture, 125 efficacy, 125 cholesterol, 247
adverse drug reaction, 59 eggs, 583 density, 401
airway inflammation, 323 electrocardiogram, 48 left cardiac sympathetic denervation, 39
analgesia, 138 electrocardiography, 7, 91 levofloxacin, 179
angina pectoris, 276 electrophysiology, 48 lipid-lowering therapy, 247
anticoagulants, 173 endothelial lipids, 401, 481
aortitis, 615 cells, 339, 381 lipoprotein, 267, 437
apo B, 247 function, 107 long QT syndrome, 39, 59, 70, 91
apoB/apoA-lI ratio, 455 endothelium, 155, 569 loop diuretics, 117
apolipoprotein, 48 1] epidemiologic study, 410 low-density lipoprotein, 473
Al, 462, 473 epidemiology, 164, 173
A-I, 259, 447 ERK, 373 magA gene, 606
B, 259, 462 external counterpulsation, 276 matrix metalloproteinase-3, 530
B and A-I, 493 mechanosignal transduction, 373
apoplipoprotein B, 473 familial combined hyperlipidaemia, 107 mechanotransduction, 339, 364, 381
arginine, 199 fatal men and women, 520
arrhythmia, 48, 81 events, 259 meta-analysis, 481
arterial structure and compliance, 155 myocardial infarction, 455 metabolic syndrome X, 561
Asian, 285 fetal programming, 155 metabolism, 437
asthma, 323 fibrates, 462 microcirculation, 155
asymmetric dimethylarginine, 199 fluid shear stress, 373 migrants, 418
atherosclerosis, 267, 393, 437, 447, fluoroquinolone, 179 mild primary hyperparathyroidism, 191
576, 598 fracture, 117 modifier genes, 39
atrial fibrillation, 173, 296 mortality, 410, 520
autoimmune disease, 219 gastro-oesophageal reflux, 323 mRNA
autoinflammatory disorder, 209 gender, 530 polyadenylaiton, 351
genetic lipoprotein, 473 transcription, 351
bacteraemia, 179, 606 genetics, 39 multidrug resistance protein-1, 351
blood pressure, 364, 553 gestodene, 199 multiple endocrine neoplasia 1, 428
body glipizide, 553 myocardial infarction, 164, 259, 296,
fat distribution, 107 glucose 530
mass index, 314 and insulin metabolism, 553
bone, 191] tolerance, 553 neuroendocrine, 138
mineral density, 191 glycocalyx, 339, 393 NFxB, 351
breath condensate, glycosaminoglycans, 339 nitric oxide, 339
guidelines, 247 synthase, 351]
calcium, 81, 539 nonocclusive mesenteric ischaemia, 305
calmodulin kinase II, 81 haemodilution, 364
cancer, 219 HDL, 437 obesity, 314, 56]
cardiac hepatic lipase, 401 oestradiol, 199
arrhythmias, 91] high-density lipoprotein, 447, 473 offspring mortality, 285
electrophysiology, 7, 91 hyaluronan, 393 opiate, 138
ion channels, 7 hyperlgE, 615 opioid, 138
cardiovascular disease, 219, 493, 576 hyperlipidaemia, 314 osteoporosis, 117, 191, 539, 598
carotid artery, 576 hypermucoviscosity, 606 oxidative stress, 3292 3
case-control study, 117 hypertension, 314, 561, 569
cholesterol, 462, 473 parental longevity, 285
clinical PECAM-1, 373
science, 155 peripheral vascular resistance, 364
trials, 125 immune evasion, 219 pharmacogenetics, 59, 401
cohort study, 520 immunodeficiency, 615 physical activity, 583
complication, 615 incidence, 305, 410, 418 pioglitazone, 107
coronary induced sputum, 323 plasma and blood viscosity, 364
artery disease, 276, 473 inflammation, 219, 267, 447 pneumonia, 410
disease, 267, 401, 561 inherited arrhythmogenic diseases, 24 polymorphism, 530
heart disease, 247, 276, 418, 481 injury, 138 postmenopausal, 199
cross-sectional, 576 insulin sensitivity, 107 women, 598
cytomegalovirus, 219 intima-media thickness, 576 proarrhythmias, 70
intra-abdominal abscess, 209 prophylactic thymectomy, 428
developmental biology, 155 invasive syndrome, 606 prospective study, 259, 598
diabetes mellitus, 314, 561, 583 ion channels, 39
diet, 583 ischaemic heart disease, 276 OT interval, 81
dietary lipids, 583
dilatation, 615 KCNJ2 mutations, 24 reduced repolarization reserve, 59
discordance, 455 Kir2, 24 refractory pain, 276
drugs, 70 Klebsiella pneumoniae, 606 register, 314
© 2006 Blackwell Publishing Ltd
624 KEYWORD INDEX
respiratory symptoms, 520 standardization, 437 the apoB/apoA-I ratio, 493
reviews, 125 Staphylococcus aureus, 179 thymic carcinoids, 428
rifampicin, 179 statins, 462 TNFRSF1A, 209
risk, 455 stress, 138 torsades de pointes, 70
factors, 305, 418 stretch, 381 TRAPS, 209
prediction, 481, 493 stroke, 173, 259, 296, 569, 592 triglyceride, 473
benefit analysis, 296 ST-T wave abnormalities, 7 type 2 diabetes, 553
sudden
safety, 125 cardiac death, 24 urban population, 164
sepsis, 179 death, 39
serum concentration, 530 surgery, 191 venous thromboembolism
shear survival, 164 ventricle, 48
response element, 3 51 Sweden, 418 vitamin D, 539
stress, 339, 364, 38 1, 393 symmetric dimethylarginine, 199
SHP-2, 373 warfarin, 296
smooth muscle cells, 381] TC/HDL C ratio, 455
socio-economic factors, 164 testosterone, 576
© 2006 Blackwell Publishing Ltd Journal of Internal Medicine 259: 623-624

VOLUME CONTENTS iii
NO. 1, January 2006 Fracture risk in patients treated with loop
diuretics L457
L. Rejnmark, P. Vestergaard & L. Mosekilde
EDITORIAL
Journal of Internal Medicine: a journal for the
future
U. de Faire
THE 2nd KEY SYMPOSIUM: THE LONG QT
SYNDROMES NO. 2, February 2006
Contents
REVIEW ARTICLES
Introduction: ‘The long QT syndromes — from
molecule to man’ Acupuncture — a critical analysis
L. Bergfeldt E. Ernst
Molecular/genetic determinants of repolari- Opioids and opiates: analgesia with
zation and their modification by environ- cardiovascular, haemodynamic and
mental stress immune implications in critical illness
M. R. Rosen & I. S. Cohen P. E. Molina
The short QT syndrome as a paradigm to ORIGINAL ARTICLES
understand the role of potassium channels
in ventricular fibrillation Discordant twin growth in utero and
M. Cerrone, S. Noujaim & J. Jalife differences in blood pressure and
endothelial function at 8 years of age
The congenital long QT syndromes from C. Pegelow Halvorsen, E. Andolf, J. Hu,
genotype to phenotype: clinical implications C. Pilo, B. Winbladh & M. Norman
P. J. Schwartz
Survival rate 28 days after hospital admission
Amplification of spatial dispersion of with first myocardial infarction. Inverse
repolarization underlies sudden cardiac relationship with socio-economic
death associated with catecholaminergic circumstances
polymorphic VT, long QT, short QT and S. Gerward, P. Tydén, O. Hansen,
Brugada syndromes G. Engstrém, L. Janzon & B. Hedblad
C. Antzelevitch & A. Oliva
Temporal trends in the prescription of
Long QT syndrome: reduced repolarization vitamin K antagonists in patients with
reserve and the genetic link atrial fibrillation
D. M. Roden J. Friberg, G. H. Gislason, N. Gadsbeell,
J. N. Rasmussen, S. Rasmussen,
In vitro and in vivo models for testing S. Z. Abildstrom, L. Kober, M. Madsen &
arrhythmogenesis in drugs C. Torp-Pedersen
L. G. Carlsson
Levofloxacin does not decrease mortality
QT interval prolongation and arrhythmia: in Staphylococcus aureus bacteraemia
an unbreakable connection? when added to the standard treatment:
M. E. Anderson a prospective and randomized clinical trial
of 381 patients 179
Modelling and imaging cardiac repolarization E. Ruotsalainen, A. Jdrvinen, I. Koivula,
abnormalities H. Kauma, E. Rintala, J. Lumio, P. Kotilainen,
Y. Rudy M. Vaara, J. Nikoskelainen, V. Valtonen &
The Finlevo Study Group
ORIGINAL ARTICLES
Positive effect of parathyroidectomy on bone
Effects of pioglitazone in familial combined mineral density in mild asymptomatic
hyperlipidaemia primary hyperparathyroidism
E. J. Abbink, J. de Graaf, J. H. de Haan, E. Hagstrom, E. Lundgren, H. Mallmin,
A. Heerschap, A. F. Stalenhoef & C. J. Tack J. Rastad & P. Hellman
© 2006 Blackwell Publishing Ltd Journal of Internal Medicine 259: iii—vi
VOLUME CONTENTS
Oral, more than transdermal, oestrogen I. Jungner, R. M. Krauss, P. Kwiterovich,
therapy lowers asymmetric dimethylargi- S. Marcovina, C. J]. Packard, T. A. Pearson,
nine in healthy postmenopausal women: K. Srinath Reddy, R. Rosenson,
a randomized, placebo-controlled study 199 N. Sarrafzadegan, A. D. Sniderman,
M. O. Verhoeven, M. Hemelaar, A. F. Stalenhoef, E. Stein, P. J. Talmud,
M. J. van der Mooren, P. Kenemans & A. M. Tonkin, G. Walldius &
T. Teerlink K. M. S. Williams
CASE REPORT ORIGINAL ARTICLES
Intra-abdominal abscess in a patient with Stroke mortality and the apoB/apoA-I ratio:
tumour necrosis factor receptor-associated results of the AMORIS prospective study
periodic syndrome 209 G. Walldius, A. H. Aastveit & I. Jungner
S. Stjernberg-Salmela, A. Kivisaari,
P. Puolakkainen, M. Farkkild, E. Kemppainen, Composition of coronary plaques obtained
A. Ranki & T. Pettersson by directional atherectomy in stable angina:
its relation to serum lipids and statin
LETTERS TO THE EDITOR treatment
J. Solem, M. Levin, T. Karlsson, L. Grip,
A forgotten aetiology of acute hepatitis in P. Albertsson & O. Wiklund
immunocompetent patient: syphilitic
infection The immediate and long-term outcome
C. Mandache, C. Coca, F. Caro-Sampara, of enhanced external counterpulsation
F. Haberstezer, D. Coumaros, F. Blicklé & in treatment of chronic stable refractory
E. Andrés angina
P. H. Loh, A. A. Louis, J. Windram,
The use of B-type natriuretic peptide in the A. S. Rigby, J. Cook, S. Hurren, N. P. Nikolay,
management of elderly with acute dyspnoea J. Caplin & J. G. F. Cleland
(J Intern Med 2005:;258:77-85) 216
O. M. P.> JolobeP a) Parental longevit° y and mortalite y amongst
3 Japanese men and women: the JACC Study
he use of B-type natriuretic peptide in the A. Ikeda, H. Iso, H. Toyoshima, T. Kondo,
management of elderly with acute dyspnoea T. Mizoue, A. Koizumi, Y. Inaba, A. Tamakoshi
(J Intern Med 2005;258:77-85) - reply & JACC Study Group
C. Mueller
Gains and losses of warfarin therapy as
performed in an anticoagulation clinic
1. M. Njaastad, U. Abildgaard & J. F. Lassen
Fatal nonocclusive mesenteric ischaemia:
population-based incidence and risk factors
NO. 3, March 2006 S. Acosta, M. Ogren, N.-H. Sternby,
D. Bergqvist & M. Bjérck
REVIEW ARTICLES Obesity and cardiovascular risk factors in type
Does cytomegalovirus play a causative role in 2 diabetes: results from the Swedish
the development of various inflammatory National Diabetes Register
diseases and cancer? M. Ridderstrale, S. Gudbjérnsdottir,
C. Séderberg-Nauclér B. Eliasson, P. M. Nilsson & J. Cederholm
for the Steering Committee of the Swedish
Apo B versus cholesterol in estimating National Diabetes Register (NDR)
cardiovascular risk and in guiding therapy: gee - ;
report of the thirty-person/ten-country Airway inflammation in subjects with gastro-
panel : oesophageal reflux and gastro-oesophageal
P. J. Barter, C. M. Ballantyne, R. Carmena, reflux-related asthma ea
M. Castro Cabezas, M. John Chapman, G. E. Carpagnano, O. Resta, M. T. Ventura,
P. Couture, J. de Graaf, P. N. Durrington A. C. Amoruso, G. Di Gioia, T. Giliberti,
O. Faergeman, J. Frohlich, C. D. Furberg, L. Refolo & M. P. Foschino-Barbaro
C. Gagne, S. M. Haffner, S. E. Humphries,
2006 Blackwell Publishing Ltd Journal of Internal Medicine 259: